A PN17 company is a listed company that does not have a core business or has failed to meet the minimum capital or equity and companies’ shareholders’ funds.
has been classified as an affected listed issuer under Practice Note 17 of the Main Market Listing Requirements of Bursa Malaysia.
Pharmaniaga said it will need to submit a regularisation plan to the Securities Commission Malaysia within 12 months if the plan will result in a significant change in the business direction or policy of the company. “As at the date of this announcement, the company is taking the necessary steps to address its PN17 status.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pharmaniaga now a PN17 company | The Malaysian InsightBursa Malaysia labels firm financially distressed.
Read more »
Go for full doubles quota in Olympics, says TanPETALING JAYA: Two is always better than one.
Read more »
Heavy is the burden of a Red Giant but Khuzaimi’s ready to shoulder itPETALING JAYA: Bigger club, bigger responsibility but Selangor centreback Ahmad Khuzaimi Piee is game for it.
Read more »
Pharmaniaga kini syarikat bermasalah | The Malaysian InsightTahun lalu syarikat itu berdepan kesukaran untuk menjual stok vaksin Sinovac Covid-19 bernilai RM552.3 juta.
Read more »